A phase II trial to assess efficacy and safety of afatinib...

Breast Cancer Research and Treatment 2012 / 08 Vol. 134; Iss. 3

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger, Marcus Schmidt, Jacques De Grève, Patrick Neven, Luc Dirix, Walter Jonat, Matthias W. Beckmann, Jochen Schütte, Peter A. Fa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
134
Language:
english
DOI:
10.1007/s10549-012-2126-1
Date:
August, 2012
File:
PDF, 303 KB
english, 2012
Conversion to is in progress
Conversion to is failed